Summary Photodynamic therapy (PDT) may cause tumour cell destruction by direct toxicity or by inducing cellular hypoxia as a result of microcirculatory shutdown. Aminolaevulinic acid (ALA) causes cellular accumulation of protoporphyrin IX (PPIX) in cells exposed to it in excess. PPIX can be used as a photosensitizer for PDT. Microcirculatory shutdown may be induced by toxicity to the endothelial and vascular smooth muscle (VSM) cells or by release of vasoactive substances. We have studied whether PPIX is produced by endothelial, VSM and tumour cells on exposure to ALA and whether these cell lines are directly damaged by PDT in vitro. Tumour endothelial cells are angiogenic and we have, therefore, investigated the effect of cellular proliferation rates on PPIX generation. Tumour cells generate more PPIX intracellularly than the non-neoplastic cell lines studied and are correspondingly more sensitive to PDT-induced cytotoxicity. Endothelial cells are sensitive to PDT-induced cytotoxicity and accumulate between 1.5 and four times more PPIX when proliferating (as during tumourinduced angiogenesis) than when quiescent. We conclude that PPIX-mediated PDT may exert some of its effects on the microcirculation of treated tissues by direct toxicity to enothelial and VSM cells, and that this toxicity may be enhanced in the tumour microenvironment.
Photodynamic therapy (PDT) is a treatment for cancer based on the photosensitization of tumour cells and their subsequent destruction on exposure to light. Aminolaevulinic acid (ALA) is a precursor for the cellular biosynthesis of haem. There are two ratelimiting steps in this process: synthesis of ALA from succinyl CoA and glycine by the enzyme ALA synthetase and conversion of protoporphyrin IX (PPIX) to haem by the enzyme ferrochelatase (Martin et al, 1983) . Provision of cells with excess exogenous ALA bypasses the first rate-limiting step causing accumulation of PPIX, a photosensitizer that can be used in PDT. On exposure to light, reactive oxygen species are produced (van Steveninck et al, 1986; Weishaupt et al, 1989) , causing cellular damage and ultimately cell death. This damage may be direct or may result from hypoxia induced by shutdown of the tissue microcirculation. Microcirculatory shutdown has been shown to occur following PDT in vivo with both traditional porphyrin photosensitizers (Reed et al, 1989a) and, more recently, ALA-induced PDT (Roberts et al, 1994; Leveckis et al, 1995) .
The mechanism of microcirculatory shutdown induced by PDT is poorly understood. It may be caused by a direct PDT-induced cytotoxicity to the endothelial and vascular smooth muscle cells or by PDT-induced release of vasoactive substances such as prostaglandins (Reed et al, 1989b; Lindberg et al, 1994) or the impaired release of vasodilators such as nitric oxide (Gilissen et al, 1993) . PDT also has effects on mast cells (Yen et al, 1990) , which release the vasoactive substance histamine. Direct cytotoxicity to the microcirculation will only occur if the endothelial and vascular smooth muscle cells produce PPIX on exposure to ALA. At present, there is conflicting evidence as to whether this occurs. In vivo fluorescence microscopy studies of the cellular distribution of PPIX have shown accumulation by tumour cells, but little in stromal cells (fibroblasts, endothelial cells and smooth muscle cells) (Loh et al, 1993) . Bedwell et al (1992) found no fluorescence in endothelial cells, although more recently Roberts et al (1994) demonstrated fluorescence in the lining cells of tumour microvascular spaces. In vitro, human umbilical vein endothelial cells (HUVECs) have been shown to accumulate PPIX on exposure to ALA (Lim et al, 1994) , but microvascular endothelial cells (MVECs) have not been studied.
Cellular sensitivity to PDT-induced toxicity is known to be influenced by a number of factors. These include the oxygenation of the cell (Mitchell et al, 1984) , the tolerance of the cell to free radicals, which is enhanced if excess ferric iron is present (Lin and Girotti, 1995) , and the intracellular concentration of PPIX (linuma et al, 1994) , which depends on the balance between the rate of PPIX synthesis and its removal by cellular efflux and conversion to haem.
The rate of PPIX accumulation is enhanced by cellular iron depletion (linuma et al, 1994; Lim et al, 1994; Rittenhouse-Diakun et al, 1995) and a rapid cellular proliferation rate (Rebeiz et al, 1992; Schick et al, 1995) . It may be influenced by the phase of the cell cycle, the cellular availability of oxygen (Falk et al, 1959) and the pH of the extracellular fluid, which may influence ALA uptake by the cell (Bermudez-Moretti et al, 1993) . It has also been demonstrated that certain neoplastic cells have reduced activity of the enzyme ferrochelatase (Shoenfeld et al, 1988; El-Sharabasy et al, 1992) . The efflux of PPIX from a cell is thought to be an active process and may be dependent on the extracellular concentration of serum (Hanania and Malik, 1992; Fukuda et al, 1993) or, more specifically, albumin (Steinbach et al, 1995) . All of these factors may be altered in the tumour microenvironment, where there is an excess of tumour-derived angiogenic factors, local areas of hypoxia and acidosis and cellular nutrient depletion (Vaupel et al, 1989) . Endothelial cells are usually quiescent in normal tissues, but are stimulated to proliferate in the presence of tumour-derived growth factors, and they may therefore respond differently to PDT under these circumstances. The aims of this study are: (1) to investigate whether there is production and accumulation of PPIX by vascular endothelial and smooth muscle cells on exposure to ALA and whether this leads to a direct PDT-induced toxicity; (2) to compare the rate of PPIX accumulation between different cell lines; and (3) to study the effect of changes in proliferation rates that may influence PPIX accumulation and PDT sensitivity in the tumour microenvironment. The influence of proliferation rate on PPIX accumulation was studied at different phases of cell growth. Proliferation rate changes were also induced by altering the concentration of serum present in the culture media, since serum contains growth factors that stimulate cellular proliferation.
MATERIALS AND METHODS

Cell lines
Human umbilical vein endothelial cells (HUVECs) were extracted from human umbilical cords by digestion with type IV collagenase according to the method of Jaffe et al (1973) . Human microvascular endothelial cells (MVECs) were extracted from human adipose tissue by type II collagenase digestion and subsequent endothelial cell selection with anti-platelet endothelial cell adhesion molecule (PECAM)-1 monoclonal antibody (Beckton Dickinson)-coated immunomagnetic beads (Dynabeads, Dynal, UK) (Hewett and Murray, 1993) . Human dermal fibroblasts (HDFs) were extracted from adult human dermis by type A collagenase digestion (Boerhinger Mannheim, UK) and were a kind gift from S. MacNeal (Department of Medicine, University of Sheffield, UK). Vascular smooth muscle cells (VSMs) were obtained from the NIA ageing cell culture repositiory, NJ, USA, and were a non-immortalized line of bovine aortic origin. MVECs and HUVECs were fully characterized by endothelium-specific antibody labelling AGS and HT1 197 cells are immortalized tumour cell lines and were used between passages 77-101 and 14-34 respectively. VSM and HDF cells were both derived from primary extractions and are non-immortalized lines. They were used between passages 11-18 and 5-10 respectively. HUVECs and MVECs were both primarily extracted from their parent tissue in this laboratory and were used between passages 2-10 and 2-6 respectively. The primarily extracted cell lines were found to have a reduced proliferative capacity beyond these limits.
Culture methods
All cell lines were maintained in optimal growth medium (complete medium) and passaged 1-2 times per week with split ratios of 4-6 depending on the cell line. HUVECs were grown in M199 supplemented with 20% fetal calf serum (FCS), penicillin and streptomycin 1%, Hepes buffer 0.7%, heparin (40 mg 1-l) and endothelial cell growth supplement (ECGS; First Link, UK). (HPLC grade) and 0.9 M perchloric acid (Fisons, UK). Serial dilution was performed to obtain a range of concentrations from 0 to 150 ng ml-'. The optical density of these solutions was measured by spectrofluorimetry (Perkins-Elmer LS-3 fluorescence spectrometer) with excitation at 406 nm and emission at 604 nm. The standard curve produced was used to calculate the PPIX concentration in the test solutions. Similar standard curves were obtained for PPIX dissolved in the various culture media mixed with an equal volume of methanol-perchloric acid and centrifuged at 1500 g for 10 min to pellet the protein precipitate (perchloric acid causes precipitation of protein out of solution). The fluorescence intensity of the supermatant was then measured.
Test samples Intracellular PPIX. Cell suspensions (in methanol and perchloric acid, 1:1 ratio) for analysis were homogenized for 5 min at 25 000 r.p.m. with a tissue homogenizer (Ultraturrax; Janke and Kunkel, Germany). The suspension was centrifuged at 3000 g for 10 min to reduce fluorescence quenching. The supernatant was analysed spectrofluorimetrically for PPIX. The concentration of PPIX was derived from the optical density of the solution and the standard curve determined previously. Medium PPIX. At the end of the incubation period, a sample of the medium was removed and analysed for PPIX content after first being mixed with an equal volume of methanol and perchloric acid and centrifuged at 3000 g to remove the protein precipitate.
Protein assay A modified Lowry method was used to quantify the amount of protein in cell homogenates (Lowry et al, 1951) . This value was then used to calculate the amount of PPIX produced per unit of cellular protein, which allowed standardization for variations between the number of cells plated into each flask. A commercially available protein assay kit was used (Sigma Chemicals, UK). Standard solutions of bovine serum albumin were used to generate a standard curve. Test samples of cell suspensions were incubated for 24 h with 0.1 M sodium hydroxide to solubilize the protein. To 1 ml of each test and standard sample, 0.1 ml of deoxycholic acid was added. Trichloroacetic acid (0.1 ml) was then added and the sample centrifuged at 3000 g for 10 min to pellet the protein precipitate. The supernatant was decanted off and the pellet resuspended in 1 ml of modified Lowry reagent. This was incubated for 20 min and 0.5 ml of Folin and Ciocalteau's phenol reagent added. The colour was allowed to develop for 30 min and the optical density read on a spectrophotometer (Pye Unicam SP8-100 UV spectrophotometer) at 725 nm. The protein concentration of the test solutions was calculated from the standard curve.
Cell survival using an MTT assay MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, is metabolized by a mitochondrial enzyme, lactate dehydrogenase, to a coloured formazan product (Stratford and Stephens, 1989) . The optical density of the resulting solution is proportional to the number of viable cells present, which can then be used to determine cell survival and cytotoxicity.
A sample of 100 g1 of 1 mg ml-' MTT in phosphate-buffered saline (PBS/A) was added to each well of a 96-well plate after removal of half (100 gl) of the culture medium. The cells were incubated for 4 h to allow generation of the coloured formazan product. The medium was then removed and 200 ,l of dimethyl sulphoxide (DMSO) was added to each well and mixed by repeated aspiration with a Gilson pipette. The optical density (OD) was then read at 550 nm on an enzyme-linked immunosorbent assay (ELISA) 96-well PDT sensitivity of cells exposed to ALA in serum-free vs complete medium Cells were plated into 96-well plates and dosed with 1 mm ALA in either serum-free or complete medium. Light was administered at the LD50 dose (as determined above), or no light. After a further 24-h incubation, an MTT assay was performed. The percentage change in cell numbers between the control groups (no light, complete medium vs no light, serum-free medium) was then compared with the percentage change in the treatment groups.
Statistical analyses
Data was analysed using non-parametric tests. Comparison between multiple groups was by Kruskal-Wallis analysis of variance and a Mann-Whitney U-test was used to compare between two groups. Statistical significance was set at P < 0.05.
RESULTS
Characterization of cell lines
The doubling times calculated for the cell lines are shown in Figure 1 . The doubling time of HT1197 was significantly shorter than that of AGS cells (P < 0.03), which in turn was significantly less than the MVECs (P < 0.01) and HDF (P < 0.003). HUVECs grew significantly more slowly than all the other cell lines, with the exception of MVECs (P < 0.04). All non-immortalized cell lines had begun their plateau phase by day 7 when plated at 1 x 104 cells ml-l. PPIX generation Serum-free medium, exponential and plateau growth phase Exponential All of the cell lines studied produce detectable amounts of PPIX on exposure to ALA. The amount produced increased with incubation time, but a plateau effect was apparent by 24 h. Intracellular PPIX levels varied significantly between cell types after both 4 and 24 h incubation (P < 0.05). Levels were significantly higher in the neoplastic than in the non-neoplastic cell lines (Table 1) . PPIX efflux into the culture medium also varied between cell lines. The neoplastic cell lines tended to retain most of their PPIX intracellularly, with very little being detected in the medium. The reverse was true of the non-neoplastic cell lines, and in all cases more PPIX entered the medium than was retained intracellularly (Table 2) . This suggests that, at least in vitro, efflux rates are an important determinant of PPIX concentration in the cells. There was no correlation between the proliferation rate of the cell lines and either the generation or the accumulation of PPIX. Data represent the mean plus the standard error in brackets (n = 4). *P < 0.05 when compared with serum-free, exponential data using Mann-Whitney U-test. Tables 1 and 2. Complete medium, exponential growth phase
The cell lines all produced detectable levels of PPIX after incubation with ALA. However, in all cases the intracellular concentrations of PPIX were significantly reduced (P < 0.05) when compared with the concentrations produced in serum-free medium (Table 1) , whereas the proportion of PPIX in the medium was increased. The total amount of PPIX generated (intracellular plus extracellular) was significantly reduced in complete medium compared with serum-free medium in four of the cell lines (AGS, MVECs, HUVECs and HDF; P < 0.05, Table 2 ). HT1197 cells showed the reverse, with significantly more PPIX being produced in complete medium (P < 0.01 at 24 h; Table 2 ).
PDT-induced cytotoxicity MTT assay standardization
All the cell types produced significant amounts of formazan after incubation with MTT for 4 h, with the exception of HT1197, which required only 2 h to produce high levels. An initial plating density of 5 x 104 cells ml was found to produce values in the linear range of the MTT assay calibration curve for all cell types with the exception of HT1197, which had to be plated at 2.5 x 104 cells ml-'.
All the cell lines were susceptible to PDT-induced cytotoxicity. The sensitivity varied significantly between cell lines, with the two neoplastic cell lines being more sensitive than the non-neoplastic cell lines (Figure 2) . The degree of sensitivity demonstrated a good correlation with the intracellular concentration of PPIX (Table 1) .
Controls for light alone showed no significant cytotoxicity with any of the cell lines. Studies with the thermistor showed that this light source had no detectable heating effect even at 120 J cm-2.
British Journal of Cancer (1997) Incubation of the cells with ALA alone caused no detectable cytotoxicity apart from a small effect with the HT1 197 cells, which were the most PDT-sensitive cell line.
Effect of serum on PDT-induced cytotoxicity
All the cell lines (with the exception of MVECs) showed a significant reduction in cell numbers when incubated for 4 h with serum-free medium compared with serum-containing medium. This difference was most marked with the three most rapidly proliferating cell lines. All the cell lines exhibited PDT-induced cytotoxicity in the complete medium, but the degree of toxicity was reduced significantly compared with the controls in serumfree medium (data not shown).
DISCUSSION
This study has demonstrated that both macro-and microvascular endothelial cells (HUVECs and MVECs) and vascular smooth muscle cells produce sufficient PPIX after a 4-h incubation with ALA to be susceptible to PDT-induced toxicity. Four hours is the usual interval from oral dosing to light exposure in clinical PDT using ALA. These results are in contrast to in vivo fluorescence studies, which have suggested that endothelial cells and stromal cells generally produce little or no PPIX (Bedwell et al, 1992; Loh et al, 1993) . These data therefore suggest that ALA PDT-induced microcirculatory shutdown may be mediated, in part, by direct damage to these cells.
We have demonstrated that endothelial cells that are quiescent (i.e. predominantly in the Go phase of the cell cycle at the plateau phase of growth) accumulate significantly less PPIX than cells that are actively proliferating. In normal tissues, endothelial cells have a very low proliferative activity (Denekamp, 1982) . In contrast, tumour endothelial cells, which are exposed to tumour-derived angiogenic factors, will be proliferating actively, suggesting that the tumour microcirculation may be more susceptible to PDTinduced damage. Thus, the elevated PPIX production by tumour endothelial cells may enhance microvascular damage in the tumour tissue, which may increase the efficacy and selectivity of ALA-induced PDT. This study used two methods to study the influence of proliferation rates on PPIX production: use of cells in different phases of their growth curve and use of different serum concentrations in the medium. The effect of serum on PPIX production is complex. Addition of serum to the medium enhances cellular proliferation rates in both neoplastic and non-neoplastic cell lines. This effect was most pronounced for the HT1197 cells and least pronounced for the endothelial cells. Cells that are actively proliferating have a reduced availability of intracellular iron, as demonstrated by an increase in their expression of membrance transferrin receptors (Rittenhouse-Diakun, 1995) . This may be because of competition for iron by enzymes, such as ribonucleotide reductase, which is necessary for DNA synthesis (Moore and Reichard, 1964) . It is known that low levels of intracellular iron promote the accumulation of PPIX since iron is essential for the activity of the enzyme, ferrochelatase, which is responsible for the conversion of PPIX to haem (Martin et al, 1983) . Thus, factors that enhance cellular proliferation rates could result in the generation of increased cellular PPIX. However, our studies only confirmed this for the HTl 197, when the addition of serum was used to modify proliferation rates. The most striking effect of the addition of serum to the culture medium during ALA treatment of the cells was a significant reduction in the intracellular concentration of PPIX and a greater efflux of PPIX into the medium. It is known that PPIX binds to albumim in the serum (Steinbach et al, 1995) , and this will therefore enhance the PPIX concentration gradient out of the cell. However, the total amount of PPIX produced (in the medium and intracellularly) was reduced in all of the cell lines in the presence of serum with the exception of HT1197. There are two possible explanations for this anomaly. The HT1 197 cells were the most sensitive to serum deprivation in terms of a reduction in proliferation rate. The cells may, therefore, have been subjected to the most increased availability of intracellular iron as a result. This may have enhanced ferrochelatase activity and reduced PPIX accumulation by the cell. The proliferation rates of the other cell lines were not as sensitive to serum deprivation, so intracellular iron depletion may not have been so marked. The other possibility is that the transferrin present in the serum was essential for some of the cell lines to take up extracellular iron. The absence of transferrin in serum-free medium provoked intracellular iron depletion (owing to effective extracellular iron deficiency). On the basis of these findings, we suggest that the modification of the proliferative state of cells by altering the serum concentration in the medium is not ideal for the study of porphyrin metabolism in vitro as many other factors are involved that may confound the effect.
The effect of growth phase on PPIX production was dependent on whether the cells were neoplastic or non-neoplastic. The nonneoplastic cell lines, which demonstrated contact inhibition on reaching confluence, produced less PPIX (both total and intracellular) at plateau than when proliferating rapidly, consistent with previous observations (Schick et al, 1995) . The converse was true for neoplastic cell lines. These produced more PPIX when confluent compared with when actively proliferating. These cell lines did not exhibit contact inhibition, but showed a reduced growth rate when confluent, with cell layering. This is probably caused by a combination of nutrient depletion and a build-up of toxic metabolites (such as lactic acid). It has been shown that ALA is taken up into the cell by an active transport mechanism that may be pH dependent and is optimal at a pH of 5.0 (Bermudez Moretti et al, 1993) . This greater uptake of substrate from the more acidic medium may have made some contribution to the increased PPIX production in neoplastic cells. Another factor influencing PPIX production may have been competition for iron from the increased number of cells in the overconfluent flask, as has been discussed previously.
There are several limitations involved in using cells in different phases of growth to study the effect of cellular proliferation rates on PPIX generation. Not all cell lines enter a true plateau phase, but will continue to increase in number until nutrient depletion occurs, as has been seen with the cell lines in this study. Another problem is that certain cell lines will still be undergoing cell division, balanced by apoptosis, even in an apparently confluent monolayer. Depending on the rate of cell turnover, the proliferation rate of the cells may still be quite high, although it should be less than in the exponential phase of the growth curve. Finally, the cell population will be in varying phases of its cell cycle, with a higher proportion in the Go phase when the cells are confluent.
This may introduce an element of heterogeneity into the experiment, as PPIX accumulation may vary with the phase of its cell cycle (Fukuda et al, 1993) . Such an effect may reduce any difference in PPIX generation rates. Although these are problems in cell culture, they may also exist in vivo with variable PPIX production in the same cell type depending on proliferation rate and cell cycle phase. Further studies are currently underway in this laboratory to British Journal of Cancer (1997) 76(6), [705] [706] [707] [708] [709] [710] [711] [712] investigate the effect of cell cycle phase variation on PPIX generation rates.
Previous workers have used a variety of methods to alter the proliferation rates of cells, including various mitogens and a reduction in the concentration of serum in the culture medium (Fukuda et al, 1993; Rittenhouse-Diakun et al, 1995; Schick et al, 1995) . However, as we have clearly demonstrated in this study, altering serum concentrations has a more complex effect than simply changing proliferation rates. Completely removing serum introduces other factors, such as selective nutrient depletion, and in the case of some cell lines, the absence of serum-derived growth factors may trigger programmed cell death. In our experiments, a progressive fall in the number of cells in the incubation flasks was noted when serum-free medium was used.
The in vivo situation would differ for the cell lines under study, with the endothelial cells being exposed to a higher serum concentration than the other cell lines, and in normal tissues these cells would have a very low proliferative activity. Our data would suggest that even under such conditions these cells may produce enough PPIX to suffer PDT-induced cytotoxicity, and that in the tumour microenvironment, where there are excess angiogenic growth factors, acidosis and nutrient depletion, their sensitivity to PDT may be enhanced. The effect on the neoplastic elements of a tumour would possibly differ in different regions depending on how well nourished the cells were. Our data would suggest that such cells would produce more PPIX, but this effect might be counterbalanced if the cells were in a hypoxic region of the tumour, since this may reduce the toxicity of PDT and may also reduce PPIX synthesis (Falk et al, 1959) .
This study highlights the complexity of the factors influencing PPIX generation after ALA administration. When the heterogeneous cell population in a tumour is considered, this allows for the possibility of focal areas of PDT insensitivity when this method of photosensitization is used. It is this tumour selectivity that makes ALA-induced PPIX so clinically attractive as a photosensitizer, but it may limit its effectiveness. However, the effect on the microcirculation may improve the treatment efficacy, as cells that are not directly affected by PDT may succumb to the secondary hypoxia caused by microcirculatory shutdown. However, the interplay of the direct and indirect effects of PDT is not yet fully understood. Van Steveninck J, Tijssen K, Boegheim JPJ, Van Der Zee J and Dubbleman TMAR (1986) 
